JP Morgan Maintains Overweight on Alignment Healthcare, Lowers Price Target to $10

JP Morgan analyst John Stansel has maintained an Overweight rating on Alignment Healthcare (NASDAQ: ALHC) but has lowered the price target from $22 to $10. This adjustment reflects a significant change in the expected valuation of the company.